# FDA Inspection 1145782 - Adamas Pharmaceuticals, Inc. - June 28, 2021

Source: https://www.keypedia.com/records/fda_inspections/adamas-pharmaceuticals-inc/92910604-c24f-427d-8076-8f059017ec45
Source feed: FDA_Inspections

> FDA Inspection 1145782 for Adamas Pharmaceuticals, Inc. on June 28, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1145782
- Company Name: Adamas Pharmaceuticals, Inc.
- Inspection Date: 2021-06-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1016106 - 2017-04-26](https://www.keypedia.com/records/fda_inspections/adamas-pharmaceuticals-inc/bddd2c28-0667-4ffb-9c9f-61fd6dbdb852)

Company: https://www.keypedia.com/companies/adamas-pharmaceuticals-inc/b3c0a41e-8acd-4829-8f5d-00244c475ee8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c